BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1385528)

  • 1. Serologic cross-reactivities poorly reflect allelic relationships in the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2 helix.
    Hildebrand WH; Madrigal JA; Belich MP; Zemmour J; Ward FE; Williams RC; Parham P
    J Immunol; 1992 Dec; 149(11):3563-8. PubMed ID: 1385528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha 1-helix.
    Hildebrand WH; Madrigal JA; Little AM; Parham P
    J Immunol; 1992 Feb; 148(4):1155-62. PubMed ID: 1737933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the serologically defined HLA-Aw19 antigens. A genetically distinct family of HLA-A antigens comprising A29, A31, A32, and Aw33, but probably not A30.
    Kato K; Trapani JA; Allopenna J; Dupont B; Yang SY
    J Immunol; 1989 Nov; 143(10):3371-8. PubMed ID: 2478623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
    Barber LD; Percival L; Arnett KL; Gumperz JE; Chen L; Parham P
    J Immunol; 1997 Feb; 158(4):1660-9. PubMed ID: 9029102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of high sensitization to the structure of HLA class I alleles.
    Clark BD; Geer LI; Park MS; Terasaki PI
    Clin Transpl; 1991; ():347-62. PubMed ID: 1726461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and distribution of HLA-B*5002 in a Spanish population sample.
    Balas A; Santos S; García-Sánchez F; Lillo R; Merino L; Vicario JL
    Tissue Antigens; 1998 Aug; 52(2):183-6. PubMed ID: 9756408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single amino acid exchange shifts the serological reactivity of the novel HLA-B*4442 allele product from HLA-B44 to HLA-B21.
    Mrazek F; Fae I; Ambruzova Z; Raida L; Kriegova E; Indrak K; Fischer GF; Petrek M
    Int J Immunogenet; 2006 Jun; 33(3):197-200. PubMed ID: 16712651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ramifications of HLA class I polymorphism and population genetics for vaccine development.
    Dawson DV; Ozgur M; Sari K; Ghanayem M; Kostyu DD
    Genet Epidemiol; 2001 Jan; 20(1):87-106. PubMed ID: 11119299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA.
    Sekimata M; Hiraiwa M; Andrien M; Dupont E; Karaki S; Yamamoto J; Kano K; Takiguchi M
    J Immunol; 1990 Apr; 144(8):3228-33. PubMed ID: 1691230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B*1303: a new example of poor correlation between serology and structure.
    Balas A; García-Sánchez F; Vicario JL
    Hum Immunol; 1996 Jan; 45(1):32-6. PubMed ID: 8655357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA epitopes detected by serology.
    Park MS; Barbetti AA; Geer LI; Clark BD; Terasaki PI; Aoki J
    Clin Transpl; 1990; ():515-31. PubMed ID: 1715741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Several HLA alleles share overlapping peptide specificities.
    Sidney J; del Guercio MF; Southwood S; Engelhard VH; Appella E; Rammensee HG; Falk K; Rötzschke O; Takiguchi M; Kubo RT
    J Immunol; 1995 Jan; 154(1):247-59. PubMed ID: 7527812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel HLA-B*44 allele, HLA-B*4459, identified in a renal patient with aberrant B44 serology and characterized by sequence-based typing.
    Hammond L; Dunn PP
    Tissue Antigens; 2008 Nov; 72(5):494-5. PubMed ID: 18764811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.
    Keever CA; Leong N; Cunningham I; Copelan EA; Avalos BR; Klein J; Kapoor N; Adams PW; Orosz CG; Tutschka PJ
    Bone Marrow Transplant; 1994 Jul; 14(1):137-45. PubMed ID: 7951101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-J, a second inactivated class I HLA gene related to HLA-G and HLA-A. Implications for the evolution of the HLA-A-related genes.
    Messer G; Zemmour J; Orr HT; Parham P; Weiss EH; Girdlestone J
    J Immunol; 1992 Jun; 148(12):4043-53. PubMed ID: 1602142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domain.
    Hayashi H; Ennis PD; Ariga H; Salter RD; Parham P; Kano K; Takiguchi M
    J Immunol; 1989 Jan; 142(1):306-11. PubMed ID: 2909619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes.
    Kosmoliaptsis V; Dafforn TR; Chaudhry AN; Halsall DJ; Bradley JA; Taylor CJ
    Hum Immunol; 2011 Nov; 72(11):1049-59. PubMed ID: 21840357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens.
    Ellexson ME; Zhang G; Stewart D; Lau M; Teresi G; Terasaki P; Roe B; Hildebrand W
    Hum Immunol; 1995 Oct; 44(2):103-10. PubMed ID: 8847228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.